Beacon Angels members conducted the following new business at its meeting on Tuesday, January 9, 2024:

We entertained new funding proposals from the following:

• Predictive Healthcare, of Bedford, MA develops and markets a predictive postoperative patient wound healing outcome digital platform called MyHealthPal.
• Verisense Health, which provides digital health management services via proprietary wearable sensors.

We heard a follow-on funding presentation:

• Realplay, offering AI-driven sports video solutions for youth baseball and softball complexes. Selling B2B systems with a B2C subscription platform for players, parents, fans, coaches and scouts.

We considered multiple funding rounds, by Series number:

Completed

• 124 Jaia Robotics.
• 125 Imago Rehab.

Pending

• 112B Theromics, developing tumor-targeting therapies;
• 122 GelMEDIX, developing gel-form eye therapies; and
• 123 Xeno, developing a weight-loss pill; and
• 126 Mybiometry, offering early warning of asthma attacks up to 20 days in advance using intelligent diagnostics and connected monitoring.

Members reported on companies in due diligence:

• RealNose, offers AI-trained, bio-programmable olfactory sensors that map scent profiles, initially to help doctors detect prostate cancer in patients.
• RestauRent, a B2B SAAS platform to directly book private events at venues that have event space for 15-300+ guests.